Effect of preterm chorioamnionitis on lung ultrasound score used to guide surfactant replacement.


Journal

Pediatric pulmonology
ISSN: 1099-0496
Titre abrégé: Pediatr Pulmonol
Pays: United States
ID NLM: 8510590

Informations de publication

Date de publication:
10 2023
Historique:
revised: 27 05 2023
received: 25 04 2023
accepted: 18 06 2023
medline: 23 10 2023
pubmed: 28 6 2023
entrez: 28 6 2023
Statut: ppublish

Résumé

Lung ultrasound score (LUS) accurately guides surfactant replacement in preterm neonates with respiratory distress syndrome due to surfactant deficiency. However, surfactant deficiency is not the unique pathobiological feature, as there may be relevant lung inflammation, such as in certain cases of clinical chorioamnionitis (CC). We aim to investigate if CC influences LUS and ultrasound-guided surfactant treatment. Retrospective (2017-2022), large, cohort study targeted to recruit a homogeneous population treated with unchanged respiratory care policy and lung ultrasound protocol. Patients with (CC+: 207) and without (CC-: 205) chorioamnionitis were analyzed with propensity score matching and subsequent additional multivariate adjustments. LUS was identical at unmatched and matched comparisons. Consistently, at least one surfactant dose was given in 98 (47.3%) and 83 (40.5%) neonates in the CC+ and CC- matched cohorts, respectively (p = .210). Multiple doses were needed in 28 (13.5%) and 21 (10.2%) neonates in the CC+ and CC- cohorts, respectively (p = .373). Postnatal age at surfactant dosing was also similar. LUS was higher in patients who were diagnosed with neonatal acute respiratory distress syndrome (NARDS) (CC+ cohort: 10.3 (2.9), CC- cohort: 11.4 (2.6)), than in those without NARDS (CC+ cohort: 6.1 (3.7), CC- cohort: 6.2 (3.9); p < .001, for both). Surfactant use was more frequent in neonates with, than in those without NARDS (p < .001). Multivariate adjustments confirmed NARDS as the variable with greater effect size on LUS. CC does not influence LUS in preterm neonates, unless inflammation is enough severe to trigger NARDS. The occurrence of NARDS is key factor influencing the LUS.

Identifiants

pubmed: 37378462
doi: 10.1002/ppul.26576
doi:

Substances chimiques

Pulmonary Surfactants 0
Surface-Active Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2761-2768

Informations de copyright

© 2023 Wiley Periodicals LLC.

Références

Raimondi F, Yousef N, Migliaro F, Capasso L, De Luca D. Point-of-care lung ultrasound in neonatology: classification into descriptive and functional applications. Pediatr Res. 2021;90(3):524-531. doi:10.1038/s41390-018-0114-9
Singh Y, Tissot C, Fraga MV, et al. International evidence-based guidelines on Point of Care Ultrasound (POCUS) for critically ill neonates and children issued by the POCUS Working Group of the European Society of Paediatric and Neonatal Intensive Care (ESPNIC). Crit Care. 2020;24(1):65. doi:10.1186/s13054-020-2787-9
Autilio C, Echaide M, Benachi A, et al. A noninvasive surfactant adsorption test predicting the need for surfactant therapy in preterm infants treated with continuous positive airway pressure. J Pediatr. 2017;182:66-73. doi:10.1016/j.jpeds.2016.11.057
Biasucci DG, Loi B, Centorrino R, et al. Ultrasound-assessed lung aeration correlates with respiratory system compliance in adults and neonates with acute hypoxemic restrictive respiratory failure: an observational prospective study. Respir Res. 2022;23(1):360. doi:10.1186/s12931-022-02294-1
Brat R, Yousef N, Klifa R, Reynaud S, Shankar Aguilera S, De Luca D. Lung ultrasonography score to evaluate oxygenation and surfactant need in neonates treated with continuous positive airway pressure. JAMA Pediatr. 2015;169(8):e151797. doi:10.1001/jamapediatrics.2015.1797
De Martino L, Yousef N, Ben-Ammar R, Raimondi F, Shankar-Aguilera S, De Luca D. Lung ultrasound score predicts surfactant need in extremely preterm neonates. Pediatrics. 2018;142(3):e20180463. doi:10.1542/peds.2018-0463
Razak A, Faden M. Neonatal lung ultrasonography to evaluate need for surfactant or mechanical ventilation: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2020;105(2):164-171. doi:10.1136/archdischild-2019-316832
Capasso L, Pacella D, Migliaro F, et al. Can lung ultrasound score accurately predict surfactant replacement? A systematic review and meta-analysis of diagnostic test studies. Pediatr Pulmonol. 2023;58:1427-1437. doi:10.1002/ppul.26337
Bahadue FL, Soll R. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 2012;11(11):CD001456. doi:10.1002/14651858.CD001456.pub2
De Luca D, Autilio C, Pezza L, Shankar-Aguilera S, Tingay DG, Carnielli VP. Personalized medicine for the management of RDS in preterm neonates. Neonatology. 2021;118(2):127-138. doi:10.1159/000513783
Raschetti R, Yousef N, Vigo G, et al. Echography-guided surfactant therapy to improve timeliness of surfactant replacement: a quality improvement project. J Pediatr. 2019;212:137-143. doi:10.1016/j.jpeds.2019.04.020
Rodriguez-Fanjul J, Jordan I, Balaguer M, Batista-Muñoz A, Ramon M, Bobillo-Perez S. Early surfactant replacement guided by lung ultrasound in preterm newborns with RDS: the ULTRASURF randomised controlled trial. Eur J Pediatr. 2020;179(12):1913-1920. doi:10.1007/s00431-020-03744-y
Higgins RD, Saade G, Polin RA, et al. Evaluation and management of women and newborns with a maternal diagnosis of chorioamnionitis: summary of a workshop. Obstet Gynecol. 2016;127(3):426-436. doi:10.1097/AOG.0000000000001246
Jackson CM, Mukherjee S, Wilburn AN, et al. Pulmonary consequences of prenatal inflammatory exposures: clinical perspective and review of basic immunological mechanisms. Front Immunol. 2020;11:1285. doi:10.3389/fimmu.2020.01285
De Luca D, Foligno S, Autilio C, et al. Secretory phospholipase A2 expression and activity in preterm clinical chorioamnionitis with fetal involvement. Am J Physiol Lung Cell Mol Physiol. 2022;323(2):L121-L128. doi:10.1152/ajplung.00516.2021
Giambelluca S, Verlato G, Simonato M, et al. Chorioamnionitis alters lung surfactant lipidome in newborns with respiratory distress syndrome. Pediatr Res. 2021;90(5):1039-1043. doi:10.1038/s41390-021-01371-3
Been JV, Rours IG, Kornelisse RF, Jonkers F, de Krijger RR, Zimmermann LJ. Chorioamnionitis alters the response to surfactant in preterm infants. J Pediatr. 2010;156(1):10-15. doi:10.1016/j.jpeds.2009.07.044
De Luca D, Tingay DG, van Kaam AH, et al. Epidemiology of neonatal acute respiratory distress syndrome: prospective, multicenter, international cohort study. Pediatric Critical Care Medicine. 2022;23(7):524-534. doi:10.1097/PCC.0000000000002961
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344-349. doi:10.1016/j.jclinepi.2007.11.008
Aziz K, Lee HC, Escobedo MB, et al. Part 5: neonatal resuscitation: 2020 American heart association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Pediatrics. 2021;147(suppl 1):e2020038505E. doi:10.1542/peds.2020-038505E
American College of Obstetricians and Gynecologists (ACOG). Committee Opinion No. 684: delayed umbilical cord clamping after birth. Obstet Gynecol. 2017;129(1):e5-e10. doi:10.1097/AOG.0000000000001860
American College of Obstetricians and Gynecologists (ACOG). SMFM Committee Opinion No 652: magnesium sulfate use in obstetrics. Obstet Gynecol. 2016;127(1):e52-e53. doi:10.1097/AOG.0000000000001267
Parry G, Tucker J, Tarnow-Mordi W. CRIB II: an update of the clinical risk index for babies score. Lancet. 2003;361(9371):1789-1791. doi:10.1016/S0140-6736(03)13397-1
Been JV, Vanterpool SF, de Rooij JDE, et al. A clinical prediction rule for histological chorioamnionitis in preterm newborns. PLoS One. 2012;7(10):e46217. doi:10.1371/journal.pone.0046217
Dell'orto V, Bourgeois-Nicolaos N, Rouard C, et al. Cell count analysis from nonbronchoscopic bronchoalveolar lavage in preterm infants. J Pediatr. 2018;200:30-37. doi:10.1016/j.jpeds.2018.04.074
Gizzi C, Klifa R, Pattumelli M, et al. Continuous positive airway pressure and the burden of care for transient tachypnea of the neonate: retrospective cohort study. Am J Perinatol. 2015;32(10):939-943. doi:10.1055/s-0034-1543988
De Luca D, van Kaam AH, Tingay DG, et al. The Montreux definition of neonatal ARDS: biological and clinical background behind the description of a new entity. Lancet Respir Med. 2017;5(8):657-666. doi:10.1016/S2213-2600(17)30214-X
De Luca D, Baroni S, Vento G, et al. Secretory phospholipase A2 and neonatal respiratory distress: pilot study on broncho-alveolar lavage. Intensive Care Med. 2008;34(10):1858-1864. doi:10.1007/s00134-008-1224-3
American College of Obstetricians and Gynecologists (ACOG). Neonatal encephalopathy and cerebral palsy: executive summary. Obstet Gynecol. 2004;103(4):780-781. doi:10.1097/01.AOG.0000120142.83093.30
Gomond-Le Goff C, Vivalda L, Foligno S, Loi B, Yousef N, De Luca D. Effect of different probes and expertise on the interpretation reliability of point-of-care lung ultrasound. Chest. 2020;157(4):924-931. doi:10.1016/j.chest.2019.11.013
Ollier V, Loi B, Rivaud C, et al. Semi-quantitative lung ultrasound score during ground transportation of outborn neonates with respiratory failure. Eur J Pediatr. 2022;181(8):3085-3092. doi:10.1007/s00431-022-04488-7
Fortas F, Loi B, Centorrino R, et al. Enhanced INSURE (ENSURE): an updated and standardised reference for surfactant administration. Eur J Pediatr. 2022;181(3):1269-1275. doi:10.1007/s00431-021-04301-x
Cogo PE, Facco M, Simonato M, et al. Pharmacokinetics and clinical predictors of surfactant redosing in respiratory distress syndrome. Intensive Care Med. 2011;37(3):510-517. doi:10.1007/s00134-010-2091-2
De Luca D, Centorrino R. Nasal high-frequency ventilation. Clin Perinatol. 2021;48(4):761-782. doi:10.1016/j.clp.2021.07.006
Nguyen TL, Collins GS, Spence J, et al. Double-adjustment in propensity score matching analysis: choosing a threshold for considering residual imbalance. BMC Med Res Methodol. 2017;17(1):78. doi:10.1186/s12874-017-0338-0
Piastra M, De Luca D, Marzano L, et al. The number of failing organs predicts non-invasive ventilation failure in children with ALI/ARDS. Intensive Care Med. 2011;37(9):1510-1516. doi:10.1007/s00134-011-2308-z
Jobe AH. Effects of chorioamnionitis on the fetal lung. Clin Perinatol. 2012;39(3):441-457. doi:10.1016/j.clp.2012.06.010
De Luca D, van Kaam AH, Tingay DG, et al. Lung ultrasound and neonatal ARDS: is Montreux closer to Berlin than to Kigali?-Authors' reply. Lancet Respir Med. 2017;5(11):e32. doi:10.1016/S2213-2600(17)30380-6
Yousef N, Vigo G, Shankar-Aguilera S, De Luca D. Semiquantitative ultrasound assessment of lung aeration correlates with lung tissue inflammation. Ultrasound MedBiol. 2020;46(5):1258-1262. doi:10.1016/j.ultrasmedbio.2020.01.018

Auteurs

Laura Vivalda (L)

Division of Pediatrics and Neonatal Critical Care, "A. Béclère" Medical Center, Paris-Saclay University Hospitals, APHP, Paris, France.

Barbara Loi (B)

Division of Pediatrics and Neonatal Critical Care, "A. Béclère" Medical Center, Paris-Saclay University Hospitals, APHP, Paris, France.
Physiopathology and Therapeutic Innovation Unit-INSERM U999, Paris-Saclay University, Paris, France.

Valeria Bisceglie (V)

Division of Pediatrics and Neonatal Critical Care, "A. Béclère" Medical Center, Paris-Saclay University Hospitals, APHP, Paris, France.

Rafik Ben-Ammar (R)

Division of Pediatrics and Neonatal Critical Care, "A. Béclère" Medical Center, Paris-Saclay University Hospitals, APHP, Paris, France.

Daniele De Luca (D)

Division of Pediatrics and Neonatal Critical Care, "A. Béclère" Medical Center, Paris-Saclay University Hospitals, APHP, Paris, France.
Physiopathology and Therapeutic Innovation Unit-INSERM U999, Paris-Saclay University, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH